Pneumococcal 15-Valent Conjugate Vaccine Approved for Pediatric Use
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
The researchers found that the trend in adjusted obesity prevalence increased over 20 years, particularly among adolescents from low-SES households.
Pediatric emergency medical encounters related to physical abuse were reduced during the COVID-19 pandemic.
After a final sign-off on Saturday from the head of the U.S. CDC, COVID-19 vaccines for children younger than 5 years have finally become a reality.
No increase in pediatric hepatitis or adenovirus types 40/41 has been seen recently in the United States.
The U.S. FDA’s vaccine advisory panel will decide whether to give EUA of Moderna’s COVID-19 vaccine in children aged 6 to 17.
Researchers assessed the influence of intrapartum antibiotic prophylaxis on the emergence of antimicrobial resistant Group B streptococcal isolates.
The addition of menthol to cigarettes may increase smoking frequency and nicotine dependence among youth.
Researchers assessed variations among clinical practice guidelines on the management of COVID-19 in children.
For pediatric patients with prior COVID-19 or MIS-C, cross-reactive immunity against the SARS-CoV-2 omicron variant is low.